Philip Empey
@philempey.bsky.social
Clinical Pharmaceutical Scientist, University of Pittsburgh School of Pharmacy. Pharmacogenomics researcher and implementer.
Congratulations to University of Pittsburgh School of Pharmacy Clinical Pharmaceutical Scientist program student Madeline Kreider, PharmD, in my laboratory on her successful PhD defense today!
June 12, 2025 at 10:26 PM
Congratulations to University of Pittsburgh School of Pharmacy Clinical Pharmaceutical Scientist program student Madeline Kreider, PharmD, in my laboratory on her successful PhD defense today!
It was fun speaking with James Hoffman at #ASHPFutures25 today on pharmacists scaling up #PGx implementation through informatics. Lot of progress in the field with over half the audience implementing. Great audience participation and discussions of best practices!
June 9, 2025 at 11:28 PM
It was fun speaking with James Hoffman at #ASHPFutures25 today on pharmacists scaling up #PGx implementation through informatics. Lot of progress in the field with over half the audience implementing. Great audience participation and discussions of best practices!
Congratulations to PittPharmacy @pittpgx.bsky.social Clinical Pharmaceutical Scientist program student Dr. Andrew Haddad in my laboratory on his successful PhD defense today - outstanding work!
February 24, 2025 at 10:26 PM
Congratulations to PittPharmacy @pittpgx.bsky.social Clinical Pharmaceutical Scientist program student Dr. Andrew Haddad in my laboratory on his successful PhD defense today - outstanding work!
Congrats @maxpgx.bsky.social and team. Some important insights here RE: hybrid‐effectiveness trial design for investigators designing #PGx clinical trials as well as for implementations striving to change prescribing practices with PGx.
pmc.ncbi.nlm.nih.gov/articles/PMC...
pmc.ncbi.nlm.nih.gov/articles/PMC...
A Randomized Hybrid‐Effectiveness Trial Comparing Pharmacogenomics (PGx) to Standard Care: The PGx Applied to Chronic Pain Treatment in Primary Care (PGx‐ACT) Trial
This trial aimed to identify the effects of providing pharmacogenomic (PGx) results and recommendations for patients with chronic pain treated in primary care practices compared to standard care. An o...
pmc.ncbi.nlm.nih.gov
February 21, 2025 at 5:37 AM
Congrats @maxpgx.bsky.social and team. Some important insights here RE: hybrid‐effectiveness trial design for investigators designing #PGx clinical trials as well as for implementations striving to change prescribing practices with PGx.
pmc.ncbi.nlm.nih.gov/articles/PMC...
pmc.ncbi.nlm.nih.gov/articles/PMC...
